杭州默佳生物科技有限公司
Member Center
Go
杭州默佳生物科技有限公司
News
副标题
More
Premier calls for deepening health reform
FENGHUA Launches New Quantitative Determination Reagents for HBV
Stryker announces definitive agreement to acquire NOVADAQ Technologies Inc.
PerkinElmer to Acquire EUROIMMUN for Approximately $1.3 Billion
New Random Access Chemiluminescent Assay for Inflammatory Bowel Disease Launched
Message
Telephone
Map